We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$5.86B
AUM Growth
-$424M
Cap. Flow
-$622M
Cap. Flow %
-10.61%
Top 10 Hldgs %
20.25%
Holding
146
New
12
Increased
44
Reduced
68
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 19.39%
2 Financials 17.89%
3 Technology 14.84%
4 Industrials 11.8%
5 Consumer Discretionary 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMTC
76
DELISTED
Bryn Mawr Bank Corp
BMTC
$34.9M 0.6%
1,148,270
+208,845
+22% +$6.25M
FUL icon
77
H.B. Fuller
FUL
$3B
$34.5M 0.59%
805,640
+78,930
+11% +$3.38M
WASH icon
78
Washington Trust Bancorp
WASH
$748M
$33.9M 0.58%
888,705
-550
-0.1% -$20.9K
EPAY
79
DELISTED
Bottomline Technologies Inc
EPAY
$33.3M 0.57%
1,216,055
-601,755
-33% -$15.6M
PH icon
80
Parker-Hannifin
PH
$120B
$33.1M 0.57%
279,010
-80,575
-22% -$9.77M
ZTS icon
81
Zoetis
ZTS
$32.7B
$33M 0.56%
711,870
-375,165
-35% -$16.9M
EW icon
82
Edwards Lifesciences
EW
$49.4B
$32M 0.55%
1,346,130
-455,730
-25% -$10.2M
TUP
83
DELISTED
Tupperware Brands Corporation
TUP
$31.9M 0.54%
462,360
-136,430
-23% -$9.22M
ATR icon
84
AptarGroup
ATR
$8.69B
$31.5M 0.54%
496,045
-143,300
-22% -$9.22M
GHDX
85
DELISTED
Genomic Health, Inc.
GHDX
$30.8M 0.53%
1,007,555
-209,620
-17% -$6.66M
POST icon
86
Post Holdings
POST
$4.42B
$30.4M 0.52%
991,611
-380,586
-28% -$11.6M
CLB icon
87
Core Laboratories
CLB
$455M
$30.1M 0.51%
287,665
-79,690
-22% -$8.49M
ACH
88
Accendra Health
ACH
$254M
$29.8M 0.51%
879,210
+207,810
+31% +$7.24M
NPO icon
89
Enpro
NPO
$6.26B
$28.7M 0.49%
434,440
-148,970
-26% -$9.53M
TFX icon
90
Teleflex
TFX
$5.96B
$28.3M 0.48%
234,615
-70,470
-23% -$8.15M
XLNX
91
DELISTED
Xilinx Inc
XLNX
$28.2M 0.48%
665,575
-236,320
-26% -$9.69M
INDB icon
92
Independent Bank
INDB
$4.04B
$28.1M 0.48%
639,395
+51,370
+9% +$2.11M
BCR
93
DELISTED
CR Bard Inc.
BCR
$28.1M 0.48%
167,610
-93,015
-36% -$15.9M
ZBH icon
94
Zimmer Biomet
ZBH
$18.8B
$27.6M 0.47%
241,823
-72,234
-23% -$8.24M
WAT icon
95
Waters Corp
WAT
$37.3B
$27.1M 0.46%
218,250
+34,110
+19% +$4.07M
SLH
96
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
$26.7M 0.45%
516,170
-386,730
-43% -$20.4M
IOSP icon
97
Innospec
IOSP
$2.09B
$26.4M 0.45%
569,005
-4,420
-0.8% -$190K
LDL
98
DELISTED
Lydall, Inc.
LDL
$26M 0.44%
819,045
+332,330
+68% +$10.1M
ALGN icon
99
Align Technology
ALGN
$12.9B
$23.5M 0.4%
+436,215
New +$24.9M
MTD icon
100
Mettler-Toledo International
MTD
$28.1B
$23.3M 0.4%
70,800
-35,940
-34% -$11.1M

Similar funds

Champlain Investment Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Champlain Investment Partners held 146 positions worth $5.86B, down 6.8% from $6.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners withdrew a net $622M in Q1 2015, closing 15 positions and reducing 68 holdings. Its most notable exit was CAREFUSION CORPORATION, an estimated $75.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

Against the trend, Champlain Investment Partners opened a new position in Align Technology worth $23.5M.

  • Champlain Investment Partners's largest Q1 2015 buy was Align Technology: 436,215 shares worth $23.5M.
  • Champlain Investment Partners added most to Insulet in Q1 2015, an estimated $30.9M increase.
  • Champlain Investment Partners's biggest Q1 2015 reduction was CST Brands, Inc., cutting an estimated $45.6M.
  • Champlain Investment Partners fully exited CAREFUSION CORPORATION in Q1 2015, selling an estimated $75.8M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $5.86B portfolio in Q1 2015.
  • Champlain Investment Partners opened 12 new positions and closed 15 in Q1 2015.
  • Champlain Investment Partners's portfolio value fell 6.8% quarter-over-quarter to $5.86B.

Based on Champlain Investment Partners's 13F filing for Q1 2015, filed 13 May 2015.